Proteomics

Dataset Information

0

A novel method for isolation of spontaneously-released brain small extracellular vesicles


ABSTRACT: Extracellular vesicles (EVs), including small EVs (sEVs) such as exosomes, exhibit great potential for the diagnosis and treatment of brain disorders, representing an advantageous tool for Precision medicine. The latter demands high-quality human biospecimens, especially in complex disorders in which pathological and specimen heterogeneity as well diverse individual clinical profile often complicate the development of precision therapeutic schemes and patient-tailored treatments. Thus, the collection and characterization of physiologically relevant sEVs are of the utmost importance. However, standard brain EV isolation approaches rely on tissue dissociation, which can contaminate EV fractions with intracellular vesicles. Based on multiscale analytical platforms such as cryo-EM, label-free proteomics, advanced flow cytometry, and ExoView analyses, we hereby present an efficient purification method that captures a more physiologically relevant, small EV-enriched population spontaneously released by mouse and human brain tissue. The spontaneous release method of sEV yield may contribute to the characterization and biomarker profile of physiologically relevant brain-derived sEVs in brain function and pathology.

INSTRUMENT(S): Q Exactive HF-X

ORGANISM(S): Mus Musculus (mouse)

TISSUE(S): Brain

SUBMITTER: Martina Samiotaki  

LAB HEAD: Ioannis Sotiropoulos

PROVIDER: PXD031947 | Pride | 2023-03-11

REPOSITORIES: Pride

altmetric image

Publications


<h4>Background</h4>Extracellular vesicles (EVs), including small EVs (sEVs) such as exosomes, exhibit great potential for the diagnosis and treatment of brain disorders, representing a valuable tool for precision medicine. The latter demands high-quality human biospecimens, especially in complex disorders in which pathological and specimen heterogeneity, as well as diverse individual clinical profile, often complicate the development of precision therapeutic schemes and patient-tailored treatmen  ...[more]

Similar Datasets

2023-08-03 | PXD026712 | Pride
2023-11-13 | PXD045522 | Pride
2023-11-21 | PXD043944 | Pride
2023-11-21 | PXD043941 | Pride
2022-05-08 | PXD032767 | Pride
2023-11-06 | PXD038693 | Pride
2024-03-14 | GSE243611 | GEO
2024-02-15 | PXD045026 | Pride
2024-03-14 | GSE255462 | GEO
2021-08-06 | PXD023889 | Pride